Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01577602 · ClinicalTrials.gov registry record · NA

Standard Medication Reconciliation Protocol in the Primary Care Office-based Setting

A NA study, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
424
Enrollment target

NCT01577602: Completed NA study, sponsored by The Cleveland Clinic.

NCT01577602 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 424 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01577602, a NA study, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
424 participants
Enrollment target

Study Summary

The purpose of this study is to determine if two basic medical office visit interventions improve the agreement of medication lists between electronic medical record and patient self, home-based report. The interventions are: * giving patients a printed list of medications before the visit * asking the patients about their medications with a scripted, open ended question.

Primary Outcome

To document medications patients report taking, a pharmacist will conduct a detailed phone interview with the patient within a week of the office visit using a prepared script. The pharmacist will note any discrepancies between the EMR and the patient's self report. In order to be considered in full agreement, the medication list and patient report must agree on the five following elements: 1) name, 2) dose, 3) frequency, 4) route, and 5) PRN status.

Interventions

  • OTHER Combined intervention
  • OTHER Printed medication list
  • OTHER Open ended question

Trial Details

FieldValue
Enrollment Target 424 participants
Start Date 2011-10
Est. Completion 2012-05
Phase NA
The Cleveland Clinic

688 total trials

What the finished NCT01577602 record still lists

NCT01577602 is an interventional study that assigns participants to a tested intervention. The registered 424 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).

The record links to 0 conditions, and to 3 interventions - of which Combined intervention is the first listed.

NCT01577602 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01577602 about?

NCT01577602 is a clinical study titled "Standard Medication Reconciliation Protocol in the Primary Care Office-based Setting". The purpose of this study is to determine if two basic medical office visit interventions improve the agreement of medication lists between electronic medical record and patient self, home-based report. The interventions are: * giving patients a printed list of medications before the visit * asking...

What is the current status of trial NCT01577602?

This trial is currently completed. It is a NA study. The enrollment target is 424 participants. The study started on 2011-10. Estimated completion is 2012-05.

What interventions are being tested in trial NCT01577602?

The interventions under investigation include: Combined intervention (OTHER), Printed medication list (OTHER), Open ended question (OTHER).

Who is sponsoring clinical trial NCT01577602?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01577602's enrollment target sits among peer trials

424 238th of 2000 higher than 1,763 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05632770 · 424 participants · NA

    A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems

  • NCT05733767 · 424 participants · Phase 2

    Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study

  • NCT06978127 · 424 participants · NA

    Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients

  • NCT07140913 · 424 participants · Phase 3

    A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01577602, the US trial registry maintained by the National Library of Medicine. NCT01577602 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.